THE JULIUS CLINICAL SOLUTION FOR VACCINES CLINICAL TRIALS
The threat by infectious diseases in both paediatrics and adults is deepened by the continued emergence of new, unrecognised pathogens and the re-emergence of old infectious diseases, creating a never-ending cycle. At Julius Clinical we manage global clinical drug trials that will have a major impact on the development of novel vaccines and treatments for infectious diseases and will make a real difference to people’s lives around the world.
Julius Clinical provides four key success criteria for conducting vaccine clinical trials;
- Scientific excellence through our close working relationship with global Key Opinion Leaders in the vaccines field
- Operational in-house expertise and track record in running vaccine clinical trials
- A global and committed scientific network of academic leaders who guarantee access to expert sites and patient populations across the world
- Experience and capabilities to serve as the main investigational site